Justin F. Gainor
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, CAR-T cell therapy research
Most-Cited Works
- → Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer(2015)8,491 cited
- → Lung cancer(2021)2,430 cited
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing(2018)1,404 cited
- → EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis(2016)1,214 cited
- → Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer(2016)1,131 cited
- → Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis(2011)896 cited
- → The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer(2014)837 cited
- → Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer(2020)816 cited
- → Patient-derived models of acquired resistance can identify effective drug combinations for cancer(2014)731 cited